BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 156018)

  • 21. Amantadine in Huntington's chorea.
    Weiner WJ; Klawans HL
    N Engl J Med; 1972 Jan; 286(2):106. PubMed ID: 4256208
    [No Abstract]   [Full Text] [Related]  

  • 22. A double blind trial of sulpiride in Huntington's disease and tardive dyskinesia.
    Quinn N; Marsden CD
    J Neurol Neurosurg Psychiatry; 1984 Aug; 47(8):844-7. PubMed ID: 6236286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homovanilic acid in Huntington's disease and Sydenham's chorea.
    Cunha L; Oliveira CR; Diniz M; Amaral R; Conçalves AF; Pio-Abreu J
    J Neurol Neurosurg Psychiatry; 1981 Mar; 44(3):258-61. PubMed ID: 6453208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bromocriptine holiday: effects on dopamine receptors and turning behavior in rats.
    Kenny AM; Schneider MB; Baden DR; Pfeiffer RF; Murrin LC
    Neurology; 1986 Mar; 36(3):400-4. PubMed ID: 3081831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EMD 23,448: effects of a putative dopamine autoreceptor agonist in chorea.
    Newman RP; Tamminga CA; Chase TN; LeWitt PA
    J Neural Transm; 1985; 61(1-2):125-9. PubMed ID: 3156964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Huntington chorea. Review of the most recent aspects of research].
    Albano C; Farinini D; Tassinari T; Caponnetto C; Bacigalupo F
    Riv Neurol; 1985; 55(4):247-55. PubMed ID: 2997905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathophysiology and therapeutic strategies in Huntington's chorea.
    Waddington JL; Cross AJ
    Lancet; 1980 Jul; 2(8187):206-7. PubMed ID: 6105376
    [No Abstract]   [Full Text] [Related]  

  • 28. Stimulation of "regulatory" dopamine receptors by bromocriptine (CB-154).
    Di Chiara G; Porceddu ML; Vargiu L; Gessa GL
    Pharmacology; 1978; 16 Suppl 1():135-42. PubMed ID: 643899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Huntington chorea.
    Tolosa ES; Sparber SB
    Arch Neurol; 1977 Jan; 34(1):58-9. PubMed ID: 137702
    [No Abstract]   [Full Text] [Related]  

  • 30. Positron emission tomography imaging of dopamine and serotonin receptors in Huntington's chorea.
    Wong DF; Wagner HN; Links JM; Dannals RF; Folstein S; Ravert HT; Tune L; Pearlson G; Frost JJ; Folstein M
    Am J Physiol Imaging; 1988; 3(1):51. PubMed ID: 2968808
    [No Abstract]   [Full Text] [Related]  

  • 31. Fluoxetine-induced exacerbation of chorea in Huntington's disease? A case report.
    Chari S; Quraishi SH; Jainer AK
    Pharmacopsychiatry; 2003 Jan; 36(1):41-3. PubMed ID: 12649776
    [No Abstract]   [Full Text] [Related]  

  • 32. Biochemical mechanisms and management of choreiform movement disorders.
    de Silva L
    Drugs; 1977 Oct; 14(4):300-10. PubMed ID: 144049
    [No Abstract]   [Full Text] [Related]  

  • 33. Late onset levodopa responsive Huntington's disease with minimal chorea masquerading as Parkinson plus syndrome.
    Reuter I; Hu MT; Andrews TC; Brooks DJ; Clough C; Chaudhuri KR
    J Neurol Neurosurg Psychiatry; 2000 Feb; 68(2):238-41. PubMed ID: 10644798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological and biochemical evidence for the dopamine agonistic effect of bromocriptine.
    Fuxe K; Fredholm BB; Ogren SO; Agnati LF; Hökfelt T; Gustafsson JA
    Acta Endocrinol Suppl (Copenh); 1978; 216():27-56. PubMed ID: 347864
    [No Abstract]   [Full Text] [Related]  

  • 35. An experimental model for Huntington's chorea?
    Zeef DH; Jahanshahi A; Vlamings R; Casaca-Carreira J; Santegoeds RG; Janssen ML; Oosterloo M; Temel Y
    Behav Brain Res; 2014 Apr; 262():31-4. PubMed ID: 24412685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bromocriptine associated with a peripheral dopamine blocking agent in treatment of Parkinson's disease.
    Agid Y; Pollak P; Bonnet AM; Signoret JL; Lhermitte F
    Lancet; 1979 Mar; 1(8116):570-2. PubMed ID: 85162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of adding the D1 agonist CY 208-243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors.
    Gomez-Mancilla B; Boucher R; Gagnon C; Di Paolo T; Markstein R; Bédard PJ
    Mov Disord; 1993 Apr; 8(2):144-50. PubMed ID: 8474480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Huntington's Chorea and dimethylaminoethanol (deanol).
    Amsterdam JD; Dubin W
    J Clin Psychiatry; 1978 Jul; 39(7):626-8. PubMed ID: 150413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of bromocriptine in Huntington chorea. Case report.
    Tsuneizumi T; Anai K; Aoba A; Yamaguchi N; Takagi H; Chishima T; Sakai T; Negishi K; Kamimura M; Takeshita T
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):823-9. PubMed ID: 7938569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of tetrabenazine for Huntington's disease-associated chorea.
    Poon LH; Kang GA; Lee AJ
    Ann Pharmacother; 2010 Jun; 44(6):1080-9. PubMed ID: 20442355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.